Partha Mukhopadhyay

Employment

• National Institutes of Health Staff Scientist
  2006 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (79)

• Chronic alcohol consumption accelerates cardiovascular aging and decreases cardiovascular reserve capacity.
  GeroScience 2025 DOI: 10.1007/s11357-025-01613-w
  +Save
• PCSK9 inhibition attenuates alcohol-associated neuronal oxidative stress and cellular injury.
  Brain, behavior, and immunity 2024 DOI: 10.1016/j.bbi.2024.04.022
  +Save
• Data-driven transcriptomics analysis identifies PCSK9 as a novel key regulator in liver aging.
  GeroScience 2023 DOI: 10.1007/s11357-023-00928-w
  +Save
• PCSK9, A Promising Novel Target for Age-Related Cardiovascular Dysfunction.
  JACC. Basic to translational science 2023 DOI: 10.1016/j.jacbts.2023.06.005
  +Save
• The endocannabinoid system promotes hepatocyte progenitor cell proliferation and maturation by modulating cellular energetics.
  Cell death discovery 2023 DOI: 10.1038/s41420-023-01400-6
  +Save
• Structural basis of selective cannabinoid CB2 receptor activation.
  Nature communications 2023 DOI: 10.1038/s41467-023-37112-9
  +Save
• Cannabinoid receptor 2 activation alleviates diabetes-induced cardiac dysfunction, inflammation, oxidative stress, and fibrosis.
  GeroScience 2022 DOI: 10.1007/s11357-022-00565-9
  +Save
• Interplay of Liver-Heart Inflammatory Axis and Cannabinoid 2 Receptor Signaling in an Experimental Model of Hepatic Cardiomyopathy.
  Hepatology (Baltimore, Md.) 2020 DOI: 10.1002/hep.30916
  +Save
• PCSK9 inhibition as a novel therapeutic target for alcoholic liver disease.
  Scientific reports 2019 DOI: 10.1038/s41598-019-53603-6
  +Save
• Cannabinoid-2 receptor activation ameliorates hepatorenal syndrome.
  Free radical biology & medicine 2019 DOI: 10.1016/j.freeradbiomed.2019.11.027
  +Save